Skrekas George, Lapatsanis Dimitrios, Stafyla Vaia, Papalambros Alexandros
General Surgery, Iaso General Hospital, Mesogeion Av., Athens, 15433, Greece.
Obes Surg. 2008 Jul;18(7):810-3. doi: 10.1007/s11695-008-9440-z. Epub 2008 Apr 8.
Laparoscopic sleeve gastrectomy (LSG) is currently gaining ground as a new option for the treatment of morbid obesity. The main advantages of this procedure are less postoperative food restrictions, no vomiting, and absence of late complications due to the lack of foreign implants. The aim of this study is to present our experience with this new bariatric technique.
Ninety three obese patients (65 females and 28 males) who underwent LSG between September 2005 and September 2007 were studied in terms of postoperative complications and weight loss.
Mean age was 38.37 +/- 10.81 years (range 19-69) and mean preoperative weight and body mass index (BMI) were 139.12 +/- 24.03 kg (range 100-210) and 46.86 +/- 6.48 kg/m(2) (range 37-66), respectively. Mean follow-up was 12.51 +/- 4.15 months (range 3-24). There were no mortalities, but there were four major and four minor postoperative complications. The mean postoperative excess weight loss (EWL) was 58.32 +/- 16.54%, while mean BMI dropped to 32.98 +/- 6.54 kg/m(2). Mean EWL 3, 6, 12, and 24 months after the operation was 31%, 53%, 67%, and 72%, respectively. Superobese patients (BMI > 50 kg/m(2)) lost less weight.
In the short term, LSG is a safe and highly effective bariatric operation more suitable for intermediate morbidly obese patients with BMI between 40 and 50 kg/m(2).
腹腔镜袖状胃切除术(LSG)作为治疗病态肥胖的一种新选择,目前正逐渐流行。该手术的主要优点是术后食物限制较少、无呕吐,且由于没有外来植入物而不存在晚期并发症。本研究的目的是介绍我们在这种新的减肥技术方面的经验。
对2005年9月至2007年9月期间接受LSG手术的93例肥胖患者(65例女性和28例男性)的术后并发症和体重减轻情况进行了研究。
平均年龄为38.37±10.81岁(范围19 - 69岁),术前平均体重和体重指数(BMI)分别为139.12±24.03千克(范围100 - 210)和46.86±6.48千克/平方米(范围37 - 66)。平均随访时间为12.51±4.15个月(范围3 - 24个月)。无死亡病例,但有4例严重和4例轻微术后并发症。术后平均超重减轻(EWL)为58.32±16.54%,而平均BMI降至32.98±6.54千克/平方米。术后3、6、12和24个月的平均EWL分别为31%、53%、67%和72%。超级肥胖患者(BMI>50千克/平方米)体重减轻较少。
短期内,LSG是一种安全且高效的减肥手术,更适合BMI在40至50千克/平方米之间的中度病态肥胖患者。